Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | GSK3B | P49841 | 5/20 | 0.44 |
| ▸ | CA1 | P00915 | 2/20 | 0.43 |
| ▸ | CA2 | P00918 | 2/20 | 0.43 |
| ▸ | CA4 | P22748 | 2/20 | 0.43 |
| ▸ | CA9 | Q16790 | 2/20 | 0.43 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.43 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4312869 | 0.87 | CA1 (0.53) | MEN1KMT2ACA1CA2CA4 | |
| SCHEMBL4301386 | 0.87 | CA1 (0.53) | MEN1KMT2ACA1CA2CA4 | |
| SCHEMBL4301863 | 0.84 | SIGMAR1 (0.48) | MEN1KMT2ACA1CA2CA4 | |
| SCHEMBL4305129 | 0.84 | SIGMAR1 (0.48) | MEN1KMT2ACA1CA2CA4 | |
| SCHEMBL4307522 | 0.80 | CHRM1 (0.49) | EPHX2CHRM1 | |
| SCHEMBL4308949 | 0.80 | CHRM1 (0.49) | EPHX2CHRM1 | |
| SCHEMBL4306408 | 0.74 | GNAI3 (0.53) | MEN1KMT2ACHRM1 | |
| SCHEMBL4308311 | 0.74 | GNAI3 (0.53) | MEN1KMT2ACHRM1 | |
| SCHEMBL4308322 | 0.74 | GNAI3 (0.53) | MEN1KMT2ACHRM1 | |
| SCHEMBL4304325 | 0.74 | GNAI3 (0.53) | MEN1KMT2ACHRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2054398-A1 | NEW HETEROCYCLIC COMPOUNDS CONTAINING NITROGEN ATOMS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME FOR TREATMENT OF CANCER | Korea Research Institute of Bioscience and Biotechnology (KR) | 2009-05-06 | — | — | EP | disclosed |
| WO-2008018778-A1 | NEW HETEROCYCLIC COMPOUNDS CONTAINING NITROGEN ATOMS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME FOR TREATMENT OF CANCER | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2008-02-14 | — | — | WO | disclosed |